# ChatTogoVar

### Summary of Variant rs121913279

#### **1-1. Variant Information**
- **rs Number**: rs121913279  
- **Gene Name**: PIK3CA  
- **Transcript Name and HGVS (Representative)**:
  - Transcript: **ENST00000263967**
    - cDNA: **c.3140A>G** or **c.3140A>T**
    - Protein: **p.His1047Arg (H1047R)** or **p.His1047Leu (H1047L)**  
  - Transcript: **NM_006218.4**
    - cDNA: **c.3140A>G** or **c.3140A>T**
    - Protein: **p.His1047Arg** or **p.His1047Leu**

#### **1-2. Relationship with Diseases**
The variant impacts the *PIK3CA* gene and has been associated with multiple diseases as per **ClinVar** curation and predictions:
- **ClinVar**:
  - Pathogenic (P) or Likely Pathogenic (LP) for conditions like:
    - CLOVES syndrome
    - Non-small cell lung carcinoma
    - Hepatocellular carcinoma
    - Breast adenocarcinoma
    - Colorectal cancer
    - Megalencephaly-capillary malformation-polymicrogyria syndrome
    - PIK3CA-related overgrowth syndrome (PROS), among others.
    
- **Prediction Tools**:
  - **AlphaMissense**: Scores for predictions:
    - A>G: **0.5381** (suggesting pathogenicity)
    - A>T: **0.438** (moderate risk)
  - **SIFT**:
    - A>G: **0.0** (deleterious)
    - A>T: **0.07** (likely deleterious)
  - **Polyphen**:
    - A>G: **0.088** (benign/tolerated)
    - A>T: **0.007** (benign)

#### **1-3. Literature About the Variant**
The variant (particularly *p.His1047Arg*) is one of the most common hotspot mutations in cancer and has been extensively studied in cancer genomics. It activates the PI3K pathway, driving oncogenic effects in various tumors, including breast, colon, and endometrial cancers.

#### **1-4. Allele Frequencies**
- Population allele frequency for **A>G**: **6.579e-05** (noted in Japanese cohort via **GEM Japan Whole Genome Aggregation** project).
- No frequency data for non-Japanese cohorts was recorded in the dataset.

#### **1-5. GWAS Results**
There is no GWAS-specific phenotype information available for this variant beyond its strong link to cancer and rare overgrowth syndromes.

#### **1-6. Related Links**
- **TogoVar**:
  - A>G Page: [rs121913279 A>G](https://togovar.biosciencedbc.jp/variant/tgv15260121)
  - A>T Page: [rs121913279 A>T](https://togovar.biosciencedbc.jp/variant/tgv417508064)
- **dbSNP**:
  - [rs121913279](https://identifiers.org/dbsnp/rs121913279)
- **ClinVar**:
  - A>G [VCV000013652](https://www.ncbi.nlm.nih.gov/clinvar/variation/13652)
  - A>T [VCV000013653](https://www.ncbi.nlm.nih.gov/clinvar/variation/13653)

---

This variant is highly relevant for cancer research and clinical diagnostics due to its established role in activating oncogenic pathways. **PIK3CA mutations** (especially *p.His1047Arg* and *p.His1047Leu*) are actionable targets in precision medicine.